November 10, 2016
Members of the Central Social Insurance Medical Council, better known as Chuikyo, on November 9 criticized the health ministry’s handling over Eli Lilly’s withdrawal of its reimbursement listing request for its psoriasis drug Taltz (ixekizumab) in August. On August 24,...read more